Roble, Belko & Company »

Viking Therapeutics shares owned by Roble, Belko & Company

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Roble, Belko & Company from 13F filings

Historical chart of Roble, Belko & Company investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Roble, Belko & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Roble, Belko & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.0k 25 40.00

More positions owned by Roble, Belko & Company

Vanguard Index Fds Etf (VTI)
Vanguard Star Fds Etf (VXUS)
Vanguard Tax-managed Fds Etf (VEA)
Vanguard Bd Index Fds Etf (BND)
Vanguard Intl Equity Index Etf (VEU)
Vanguard Whitehall Fds Etf (VYM)
Select Sector Spdr Tr Etf (XLK)
Vanguard Index Fds Etf (VV)
Spdr S&p 500 Etf Tr Etf (SPY)
Spdr Ser Tr Portfoli S&p1500 Etf (SPTM)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Blackrock Ultra Etf (ICSH)
Vanguard Index Fds Etf (VNQ)
Schwab Strategic Tr Etf (SCHB)
Vanguard Scottsdale Etf (VGIT)

View all positions for Roble, Belko & Company

Top funds holding Viking Therapeutics

Vanguard Group
Susquehanna International
FMR
BlackRock
State Street Corporation
Citadel Advisors
Morgan Stanley
Jpmorgan Chase & Co
Ameriprise Financial
Two Sigma Investments
Jane Street
Geode Capital Management
Two Sigma Advisers
UBS Group
Pictet Asset Management Holding SA

View all funds holding Viking Therapeutics